Literature DB >> 19653058

Pegylated interferon alpha-2B induced lupus in a patient with chronic hepatitis B virus infection: case report.

Sema Yilmaz1, Kadriye Akar Cimen.   

Abstract

Drug-induced lupus is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation of the offending drug. Newer biological agents such as interferons (IFN) and anti-tumor necrosis factor-alpha therapies have been involved in the induction of lupus-like syndromes. Prompt recognition and discontinuation of the suspected drug are associated with excellent outcomes in most cases. In this article, we present the case who developed lupus during therapy with pegylated-IFN alpha-2b for chronic hepatitis B virus infection after 8 months.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19653058     DOI： 10.1007/s10067-009-1239-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   3.650


  13 in total

Review 1.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

Authors:  Y Ioannou; D A Isenberg
Journal:  Arthritis Rheum       Date:  2000-07

2.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

Authors:  P Blanco; A K Palucka; M Gill; V Pascual; J Banchereau
Journal:  Science       Date:  2001-11-16       Impact factor: 47.728

3.  Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.

Authors:  Leen De Rycke; Elli Kruithof; Nancy Van Damme; Ilse E A Hoffman; Nancy Van den Bossche; Filip Van den Bosch; Eric M Veys; Filip De Keyser
Journal:  Arthritis Rheum       Date:  2003-04

4.  Drug-related lupus.

Authors:  E Hess
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

Review 5.  New concepts in the pathogenesis of drug-induced lupus.

Authors:  R L Yung; K J Johnson; B C Richardson
Journal:  Lab Invest       Date:  1995-12       Impact factor: 5.662

Review 6.  Drug-induced lupus: an update.

Authors:  S Vasoo
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 7.  Drugs recently associated with lupus syndromes.

Authors:  M J Fritzler
Journal:  Lupus       Date:  1994-12       Impact factor: 2.911

8.  Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.

Authors:  D K Wong; A M Cheung; K O'Rourke; C D Naylor; A S Detsky; J Heathcote
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

Review 9.  Drug-induced autoimmunity.

Authors:  Nancy J Olsen
Journal:  Best Pract Res Clin Rheumatol       Date:  2004-10       Impact factor: 4.098

Review 10.  Drug-induced lupus erythematosus.

Authors:  Dimitar Antonov; Jana Kazandjieva; Doncho Etugov; Dimitar Gospodinov; Nikolai Tsankov
Journal:  Clin Dermatol       Date:  2004 Mar-Apr       Impact factor: 3.541
View more
  5 in total

Review 1.  Spontaneous and antiviral-induced cutaneous lesions in chronic hepatitis B virus infection.

Authors:  Ioana Grigorescu; Dan Lucian Dumitrascu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 2.  Immunogenicity and other problems associated with the use of biopharmaceuticals.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Ther Adv Drug Saf       Date:  2011-06

Review 3.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

4.  A novel computational drug repurposing approach for Systemic Lupus Erythematosus (SLE) treatment using Semantic Web technologies.

Authors:  Adeeb Noor; Abdullah Assiri
Journal:  Saudi J Biol Sci       Date:  2021-04-02       Impact factor: 4.219

Review 5.  Safety, Tolerability, and Immunogenicity of Interferons.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.